LinaTech

Executive Summary

LinaTech, a privately held medical device and software company based in Sunnyvale, CA, specializes in comprehensive cancer care solutions including radiotherapy devices and informatics software. With regulatory approval already secured, the company focuses on enhancing treatment planning, workflow optimization, and data management for oncology clinics. Over its 25+ year history, LinaTech has established a strong foothold in the U.S. market, serving radiotherapy centers and medical oncology practices with integrated hardware and software platforms. The company's commitment to precision medicine and operational efficiency positions it well for continued growth as cancer incidence rises globally. Key competitive advantages include its proprietary treatment planning algorithms and seamless integration with existing clinical workflows, which reduce errors and improve patient outcomes. While financial details remain private, LinaTech's sustained presence and product adoption indicate a stable revenue base. Future growth will likely stem from technology upgrades, geographic expansion, and strategic partnerships.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) clearance for next-gen radiotherapy treatment planning software80% success
• Q1 2027Execution of distribution agreement in Asia-Pacific region70% success
• Q2 2027Launch of cloud-based analytics platform for cancer clinics75% success